Mounjaro is a prescription GLP-1 agonist medication that the FDA has approved to treat type 2 diabetes. Medical professionals may additionally prescribe it off-label for weight loss in persons with weight problems.The inclusion of such does not indicate an endorsement or approval on the items or companies linked. Health-related Well being Authority